Photodynamic therapy with decacationic [60]fullerene monoadducts: Effect of a light absorbing electron-donor antenna and micellar formulation

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 4, 2014, Pages 795-808

  Yin, Rui ^a,b,c   Wang, Min ^d   Huang, Ying Ying ^a,b   Huang, Huang Chiao ^a,b   Avci, Pinar ^a,b,e   Chiang, Long Y ^d   Hamblin, Michael R ^a,b,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d University of Massachusetts Lowell   (United States)

^e SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Apoptosis; Decacationic fullerene monoadducts; Light absorbing antenna; Micelles; Nanomedicine; Photodynamic therapy; Reactive oxygen species; Structure function relationship

Indexed keywords

ANTENNAS; CELL DEATH; CELL MEMBRANES; MEDICAL NANOTECHNOLOGY; MICELLES; PHOTODYNAMIC THERAPY;

DIMETHYLACETAMIDE; ENDOPLASMIC RETICULUM; FLUORESCENT PROBES; LIGHT-HARVESTING; MONO-ADDUCTS; PHOTON ABSORPTIONS; REACTIVE OXYGEN SPECIES; STRUCTURE-FUNCTION RELATIONSHIP;

FULLERENES;

DECACATIONIC 60 FULLERENE; DECACATIONIC FULLERENE; FULLERENE; REACTIVE OXYGEN METABOLITE; RED LIGHT HARVESTING ANTENNA FULLERENE CONJUGATED MONOADDUCT; UNCLASSIFIED DRUG; FULLERENE C60; FULLERENE DERIVATIVE; MICELLE;

ARTICLE; CANCER THERAPY; CELL VIABILITY; CHEMICAL STRUCTURE; CHROMATOPHORE; COMPARATIVE STUDY; ELECTRON TRANSPORT; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT ABSORPTION; MICELLE; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOTOXICITY; RED LIGHT; TRANSMISSION ELECTRON MICROSCOPY; TUMOR MICROENVIRONMENT; ULTRAVIOLET A RADIATION; WHITE LIGHT; CHEMISTRY; METABOLISM; NEOPLASMS; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES;

FULLERENES; HELA CELLS; HUMANS; MICELLES; NEOPLASMS; PHOTOCHEMOTHERAPY;

EID: 84900330384     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.11.014     Document Type: Article

References (61)

1. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011, 61:250-281.
2. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther 2004, 1:279-293.
3. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part two - cellular signalling, cell metabolism and modes of cell death. Photodiagnosis Photodyn Ther 2005, 2:1-23.
4. Satoh M., Takayanagi I. Pharmacological studies on fullerene (C60), a novel carbon allotrope, and its derivatives. J Pharmacol Sci 2006, 100:513-518.
5. Guldi D.M., Prato M. Excited-state properties of C(60) fullerene derivatives. Acc Chem Res 2000, 33:695-703.
6. Bottari G., de la Torre G., Guldi D.M., Torres T. Covalent and noncovalent phthalocyanine-carbon nanostructure systems: synthesis, photoinduced electron transfer, and application to molecular photovoltaics. Chem Rev 2010, 110:6768-6816.
7. Fujitsuka M.O., Ito O. Encyclopedia of nanoscience and nanotechnology 2004, 593-615. American Scientific Publishers, Valencia, CA. H.S. Nalwa (Ed.).
8. Robertson C.A., Evans D.H., Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 2009, 96:1-8.
9. 2. J Am Chem Soc 2003, 125:12803-12809.
10. Jensen A.W., Wilson S.R., Schuster D.I. Biological applications of fullerenes. Bioorg Med Chem 1996, 4:767-779.
11. Bosi S., Da Ros T., Spalluto G., Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 2003, 38:913-923.
12. Liao F., Saitoh Y., Miwa N. Anticancer effects of fullerene [C60] included in polyethylene glycol combined with visible light irradiation through ROS generation and DNA fragmentation on fibrosarcoma cells with scarce cytotoxicity to normal fibroblasts. Oncol Res 2011, 19:203-216.
13. Sperandio F.F., Huang Y.Y., Hamblin M.R. Antimicrobial photodynamic therapy to kill Gram-negative bacteria. Recent Patents Anti-Infect Drug Disc 2013, 8:108-120.
14. Kasermann F., Kempf C. Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res 1997, 34:65-70.
15. Sera N., Tokiwa H., Miyata N. Mutagenicity of the fullerene C60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogenesis 1996, 17:2163-2169.
16. Burlaka A.P., Sidorik Y.P., Prylutska S.V., Matyshevska O.P., Golub O.A., Prylutskyy Y.I., et al. Catalytic system of the reactive oxygen species on the C60 fullerene basis. Exp Oncol 2004, 26:326-327.
17. Mroz P., Bhaumik J., Dogutan D.K., Aly Z., Kamal Z., Khalid L., et al. Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production. Cancer Lett 2009, 282:63-76.
18. Liu J., Tabata Y. Photodynamic therapy of fullerene modified with pullulan on hepatoma cells. J Drug Target 2010, 18:602-610.
19. Wang M., Huang L., Sharma S.K., Jeon S., Thota S., Sperandio F.F., et al. Synthesis and photodynamic effect of new highly photostable decacationically armed [60]- and [70]fullerene decaiodide monoadducts to target pathogenic bacteria and cancer cells. J Med Chem 2012, 55:4274-4285.
20. Mroz P., Xia Y., Asanuma D., Konopko A., Zhiyentayev T., Huang Y.Y., et al. Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma. Nanomedicine 2011, 7:965-974.
21. Tabata Y., Murakami Y., Ikada Y. Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn J Cancer Res: Gann 1997, 88:1108-1116.
22. Sharma S.K., Chiang L.Y., Hamblin M.R. Photodynamic therapy with fullerenes in vivo: reality or a dream?. Nanomedicine (UK) 2011, 6:1813-1825.
23. Huang Y.Y., Balasubramanian T., Yang E., Luo D., Diers J.R., Bocian D.F., et al. Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery. Chem Med Chem 2012, 7:2155-2167.
24. Redmond R.W., Land E.J., Truscott T.G. Aggregation effects on the photophysical properties of porphyrins in relation to mechanisms involved in photodynamic therapy. Adv Exp Med Biol 1985, 193:293-302.
25. Jin S., Zhou L., Gu Z., Tian G., Yan L., Ren W., et al. A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells. Nanoscale 2013, 5:11910-11918.
26. Lu Z., Dai T., Huang L., Kurup D.B., Tegos G.P., Jahnke A., et al. Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (UK) 2010, 5:1525-1533.
27. Chiang L.Y., Padmawar P.A., Rogers-Haley J.E., So G., Canteenwala T., Thota S., et al. Synthesis and characterization of highly photoresponsive fullerenyl dyads with a close chromophore antenna-C(60) contact and effective photodynamic potential. J Mater Chem 2010, 20:5280-5293.
28. Klein O.J., Bhayana B., Park Y.J., Evans C.L. In vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform. Mol Pharm 2012, 9:3171-3182.
29. Evans C.L., Abu-Yousif A.O., Park Y.J., Klein O.J., Celli J.P., Rizvi I., et al. Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS One 2011, 6:e23434.
30. Wikstrom J.D., Israeli T., Bachar-Wikstrom E., Swisa A., Ariav Y., Waiss M., et al. AMPK regulates ER morphology and function in stressed pancreatic beta-cells via phosphorylation of DRP1. Mol Endocrinol 2013, 27:1706-1723.
31. Lane J.D., Allan V.J., Woodman P.G. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J Cell Sci 2005, 118:4059-4071.
32. Meesmann H.M., Fehr E.M., Kierschke S., Herrmann M., Bilyy R., Heyder P., et al. Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes. J Cell Sci 2010, 123:3347-3356.
33. Mroz P., Pawlak A., Satti M., Lee H., Wharton T., Gali H., et al. Functionalized fullerenes mediate photodynamic killing of cancer cells: type I versus type II photochemical mechanism. Free Radic Biol Med 2007, 43:711-719.
34. Yamakoshi Y., Umezawa N., Ryu A., Arakane K., Miyata N., Goda Y., et al. Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-* versus 1O2. J Am Chem Soc 2003, 125:12803-12809.
35. Nakamura E., Isobe H. Functionalized fullerenes in water. The first 10years of their chemistry, biology, and nanoscience. Acc Chem Res 2003, 36:807-815.
36. Mroz P., Tegos G.P., Gali H., Wharton T., Sarna T., Hamblin M.R. Photodynamic therapy with fullerenes. Photochem Photobiol Sci 2007, 6:1139-1149.
37. Mizuno K., Zhiyentayev T., Huang L., Khalil S., Nasim F., Tegos G.P., et al. Antimicrobial photodynamic therapy with functionalized fullerenes: quantitative structure-activity relationships. J Nanomedicine Nanotechnol 2011, 2:1-9.
38. Kornguth S.E., Kalinke T., Robins H.I., Cohen J.D., Turski P. Preferential binding of radiolabeled poly-L-lysines to C6 and U87 MG glioblastomas compared with endothelial cells in vitro. Cancer Res 1989, 49:6390-6395.
39. Ambrose E.J., Easty D.M., Jones P.C. Specific reactions of polyelectrolytes with the surfaces of normal and tumour cells. Br J Cancer 1958, 12:439-447.
40. Kim B., Han G., Toley B.J., Kim C.K., Rotello V.M., Forbes N.S. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 2010, 5:465-472.
41. Wang M., Maragani S., Huang L., Jeon S., Canteenwala T., Hamblin M.R., et al. Synthesis of decacationic [60]fullerene decaiodides giving photoinduced production of superoxide radicals and effective PDT-mediation on antimicrobial photoinactivation. Eur J Med Chem 2013, 63:170-184.
42. El-Khouly ME, Padmawar P, Araki Y, Verma S, Chiang LY, Ito O. Photoinduced processes in a tricomponent molecule consisting of diphenylaminofluorene-dicyanoethylene-methano[60]fullerene. The journal of physical chemistry. A. 2006;110:884-91.
43. Setsukinai K., Urano Y., Kakinuma K., Majima H.J., Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 2003, 278:3170-3175.
44. Sperandio F.F., Sharma S.K., Wang M., Jeon S., Huang Y.Y., Dai T., et al. Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C(7)(0) and C(8)(4)O(2) fullerene derivatives. Nanomedicine 2013, 9:570-579.
45. Bennett L.E., Ghiggino K.P., Henderson R.W. Singlet oxygen formation in monomeric and aggregated porphyrin c. J Photochem Photobiol B 1989, 3:81-89.
46. Smith G.J. The effects of aggregation on the fluorescence and the triplet state yield of hematoporphyrin. Photochem Photobiol 1985, 41:123-126.
47. Derycke A.S., de Witte P.A. Liposomes for photodynamic therapy. Adv Drug Deliv Rev 2004, 56:17-30.
48. van Nostrum C.F. Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 2004, 56:9-16.
49. Sparreboom A., Loos W.J., Verweij J., de Vos A.I., van der Burg M.E., Stoter G., et al. Quantitation of cremophor EL in human plasma samples using a colorimetric dye-binding microassay. Anal Biochem 1998, 255:171-175.
50. Gelderblom H., Verweij J., Nooter K., Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001, 37:1590-1598.
51. Kiss L., Walter F.R., Bocsik A., Veszelka S., Ozsvari B., Puskas L.G., et al. Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells. J Pharm Sci 2013, 102:1173-1181.
52. Kolosnjaj J., Szwarc H., Moussa F. Toxicity studies of fullerenes and derivatives. Adv Exp Med Biol 2007, 620:168-180.
53. Dal Forno G.O., Kist L.W., de Azevedo M.B., Fritsch R.S., Pereira T.C., Britto R.S., et al. Intraperitoneal exposure to nano/microparticles of fullerene (C(6)(0)) increases acetylcholinesterase activity and lipid peroxidation in adult zebrafish (Danio rerio) brain. BioMed Res Int 2013, 2013:623789.
54. Horie M., Nishio K., Kato H., Shinohara N., Nakamura A., Fujita K., et al. In vitro evaluation of cellular responses induced by stable fullerene C60 medium dispersion. J Biochem 2010, 148:289-298.
55. Patnaik A. Structure and dynamics in self-organized C60 fullerenes. J Nanosci Nanotechnol 2007, 7:1111-1150.
56. Kessel D. Subcellular targets for photodynamic therapy: implications for initiation of apoptosis and autophagy. J Natl Compr Canc Netw 2012, 10(Suppl. 2):S56-S59.
57. Nishiyama N., Morimoto Y., Jang W.D., Kataoka K. Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv Drug Deliv Rev 2009, 61:327-338.
58. MacDonald I.J., Morgan J., Bellnier D.A., Paszkiewicz G.M., Whitaker J.E., Litchfield D.J., et al. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives. Photochem Photobiol 1999, 70:789-797.
59. Nishiyama N., Nakagishi Y., Morimoto Y., Lai P.S., Miyazaki K., Urano K., et al. Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine. J Control Release 2009, 133:245-251.
60. Shahzidi S., Cunderlikova B., Wiedlocha A., Zhen Y., Vasovic V., Nesland J.M., et al. Simultaneously targeting mitochondria and endoplasmic reticulum by photodynamic therapy induces apoptosis in human lymphoma cells. Photochem Photobiol Sci 2011, 10:1773-1782.
61. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995, 146:3-15.